Nolan Marcos
Irvine, CANPI 1184126831
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 11.3% — the pattern of someone who eats at a lot of different presentations.
Across 111 payments — averaging $22.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$278
- Johnson & Johnson$194
- Novartis$164
- Merck$154
- Daiichi Sankyo Inc.$147
- Sobi, Inc$136
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,37797%
- Education$753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 13 | $278 |
| Johnson & Johnson | 10 | $194 |
| Novartis | 8 | $164 |
| Merck | 7 | $154 |
| Daiichi Sankyo Inc. | 8 | $147 |
| Sobi, Inc | 5 | $136 |
| Incyte Corporation | 6 | $124 |
| Karyopharm Therapeutics Inc. | 4 | $118 |
| AVEO Pharmaceuticals, Inc. | 3 | $115 |
| EMD Serono, Inc. | 5 | $115 |
| Exelixis Inc. | 5 | $99 |
| Bayer | 5 | $89 |
| Genmab U.S., Inc. | 3 | $81 |
| Astellas Pharma US Inc | 4 | $73 |
| Stemline Therapeutics Inc. | 2 | $71 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| Lilly USA, LLC | 3 | $51 |
| Beigene USA, Inc. | 2 | $51 |
| Tersera Therapeutics LLC | 2 | $49 |
| GSK | 2 | $39 |
| Pfizer | 2 | $35 |
| Beone Medicines USA, Inc. | 1 | $31 |
| Geron Corporation | 1 | $26 |
| Agios Pharmaceuticals, Inc. | 1 | $25 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| Progenics Pharmaceuticals, Inc. | 1 | $22 |
| Adaptive Biotechnologies Corporation | 1 | $20 |
| Bristol Myers Squibb | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
| Sanofi | 1 | $17 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.